These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. 2-Arylindenes and 2-arylindenones: molecular structures and considerations in the binding orientation of unsymmetrical nonsteroidal ligands to the estrogen receptor. Anstead GM; Wilson SR; Katzenellenbogen JA J Med Chem; 1989 Sep; 32(9):2163-71. PubMed ID: 2769689 [TBL] [Abstract][Full Text] [Related]
3. Torsionally and hydrophobically modified 2,3-diarylindenes as estrogen receptor ligands. Anstead GM; Peterson CS; Pinney KG; Wilson SR; Katzenellenbogen JA J Med Chem; 1990 Oct; 33(10):2726-34. PubMed ID: 2213825 [TBL] [Abstract][Full Text] [Related]
4. 2,3-Diarylindenes and 2,3-diarylindenones: synthesis, molecular structure, photochemistry, estrogen receptor binding affinity, and comparisons with related triarylethylenes. Anstead GM; Altenbach RJ; Wilson SR; Katzenellenbogen JA J Med Chem; 1988 Jul; 31(7):1316-26. PubMed ID: 3385728 [TBL] [Abstract][Full Text] [Related]
5. Optimizing of 2,3-diarylindenes as fluorescent estrogens: variation of the acceptor group, ortho substitution of the 2-ring, and C-1 methylation. Anstead GM; Katzenellenbogen JA J Med Chem; 1988 Sep; 31(9):1754-61. PubMed ID: 3411601 [TBL] [Abstract][Full Text] [Related]
6. Differential response of estrogen receptor subtypes to 1,3-diarylindene and 2,3-diarylindene ligands. Clegg NJ; Paruthiyil S; Leitman DC; Scanlan TS J Med Chem; 2005 Sep; 48(19):5989-6003. PubMed ID: 16162002 [TBL] [Abstract][Full Text] [Related]
7. Acyclic amides as estrogen receptor ligands: synthesis, binding, activity and receptor interaction. Stauffer SR; Sun J; Katzenellenbogen BS; Katzenellenbogen JA Bioorg Med Chem; 2000 Jun; 8(6):1293-316. PubMed ID: 10896109 [TBL] [Abstract][Full Text] [Related]
8. Hydroxylated triphenylacrylonitriles adopt a unique orientation within the binding site of the estrogen receptor. Pons M; Bignon E; Crastes de Paulet A; Gilbert J; Ojasoo T; Raynaud JP J Steroid Biochem; 1990 Aug; 36(5):391-7. PubMed ID: 2214759 [TBL] [Abstract][Full Text] [Related]
9. Molecular structures of metabolites and analogues of diethylstilbestrol and their relationship to receptor binding and biological activity. Duax WL; Swenson DC; Strong PD; Korach KS; McLachlan J; Metzler M Mol Pharmacol; 1984 Nov; 26(3):520-5. PubMed ID: 6548545 [TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor based imaging agents. 1. Synthesis and receptor binding affinity of some aromatic and D-ring halogenated estrogens. Heiman DF; Senderoff SG; Katzenellenbogen JA; Neeley RJ J Med Chem; 1980 Sep; 23(9):994-1002. PubMed ID: 7411555 [TBL] [Abstract][Full Text] [Related]
11. The estradiol pharmacophore: ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding site. Anstead GM; Carlson KE; Katzenellenbogen JA Steroids; 1997 Mar; 62(3):268-303. PubMed ID: 9071738 [TBL] [Abstract][Full Text] [Related]
12. Prediction of ligand binding affinity and orientation of xenoestrogens to the estrogen receptor by molecular dynamics simulations and the linear interaction energy method. van Lipzig MM; ter Laak AM; Jongejan A; Vermeulen NP; Wamelink M; Geerke D; Meerman JH J Med Chem; 2004 Feb; 47(4):1018-30. PubMed ID: 14761204 [TBL] [Abstract][Full Text] [Related]
13. Hydroxy derivatives of tamoxifen. Foster AB; Jarman M; Leung OT; McCague R; Leclercq G; Devleeschouwer N J Med Chem; 1985 Oct; 28(10):1491-7. PubMed ID: 4045924 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of 17alpha-20E-21-(4-substituted phenyl)-19-norpregna-1,3,5(10),20-tetraene-3,17beta-diols as probes for the estrogen receptor alpha hormone binding domain. Hanson RN; Lee CY; Friel CJ; Dilis R; Hughes A; DeSombre ER J Med Chem; 2003 Jul; 46(14):2865-76. PubMed ID: 12825929 [TBL] [Abstract][Full Text] [Related]
15. Preparation, receptor binding, and fluorescence properties of hexestrol-fluorophore conjugates: evaluation of site of attachment, fluorophore structure, and fluorophore-ligand spacing. Fevig TL; Lloyd JE; Zablocki JA; Katzenellenbogen JA J Med Chem; 1987 Jan; 30(1):156-65. PubMed ID: 3027331 [TBL] [Abstract][Full Text] [Related]
17. Pyrazole ligands: structure-affinity/activity relationships and estrogen receptor-alpha-selective agonists. Stauffer SR; Coletta CJ; Tedesco R; Nishiguchi G; Carlson K; Sun J; Katzenellenbogen BS; Katzenellenbogen JA J Med Chem; 2000 Dec; 43(26):4934-47. PubMed ID: 11150164 [TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor binding tolerance of 16 alpha-substituted estradiol derivatives. Fevig TL; Mao MK; Katzenellenbogen JA Steroids; 1988; 51(5-6):471-97. PubMed ID: 3242172 [TBL] [Abstract][Full Text] [Related]
19. Differential interactions of estrogens and antiestrogens at the 17 beta-hydroxy or counterpart function with the estrogen receptor. Borgna JL; Scali J Eur J Biochem; 1991 Aug; 199(3):575-85. PubMed ID: 1868844 [TBL] [Abstract][Full Text] [Related]